Tata Elxsi joins Digital Therapeutics Alliance; stock slips ~1%

23 Sep 2022 , 01:19 PM

Tata Elxsi, a prominent provider of design and technology services, has joined the Digital Therapeutics Alliance, a worldwide non-profit trade organisation dedicated to revolutionising global healthcare by promoting digital therapeutics to enhance clinical and health economic results.

This partnership with DTA offers a once-in-a-lifetime opportunity to Tata Elxsi for accelerating global digital therapies research and uptake.

“As we develop and deploy robust solution accelerators for DTx solutions, DTA provides us with a strong platform to engage in advance collaboration and incorporate the latest innovations in design and technology. This will help us to achieve better patient engagement and outcomes,” said Suhas Tamras, VP and Head of Healthcare & Life Sciences Business at Tata Elxsi.

DTA seeks to provide patient, physician, and payor access to high-quality, evidence-based digital treatments in order to enhance clinical and health economic outcomes.

At around 1.31 PM, Tata Elxsi was trading at Rs8,888.50 per piece, down by 1.09% from its previous closing of Rs8,986.55 on the BSE. The scrip touched intraday high and low of Rs9,054 and Rs8,875.95 respectively.

For feedback and suggestions, write to us at [e-mail]